Abstract:Background Primary Sjögren's syndrome (pSS) is a systemic autoimmune disease affecting predominantly exocrine glands such as salivary and lacrimal glands. Immunoglobulin G4 (IgG4)-related disease (IgG4-RD) is a new clinical concept of multi-organ diseases, which is characterized pathologically by the infiltration of IgG4-bearing plasma cells into involved organs. However, some pSS patients showed infiltration of IgG4+ plasma cells in exocrine glands. Objectives We aim to investigate the characteristics of primary Sjögren's syndrome (pSS) patients with IgG4+ plasma cells in labial salivary glands (LSGs). Methods 336 patients with pSS were enrolled. The LSG tissues from pSS patients were stained with monoclonal antibodies to IgG4 and IgG. Patients were divided into three subgroups according to histopathologic infiltration degree of IgG4+ plasma cells. The clinical and serological characteristics of patients were compared. Results 336 patients were divided into three groups according to infiltration degree of IgG4+ plasma cells: slight-IgG4 group (n=194), moderate-IgG4 group (n=106) and high-IgG4 group (n=36). The results showed that the higher IgG4+ plasma cells expression, the lower positive rates of serum anti-SSA, anti-SSB, anti-nuclear antibodies (ANA) and rheumatoid factor (RF). The comparison of extraglandular manifestations of three groups indicated that patients in high-IgG4 expression group showed a highest frequency of interstitial lung disease (30.6%) and tubulointerstitial nephritis (13.9%), whereas a lowest frequency of leucopaenia (13.9%), thrombocytopaenia (11.1%) and abnormal thyroidal function (0%). Conclusions The results showed that a considerable proportion of pSS patients could manifest abundant IgG4+ plasma cells infiltration in LSGs. These patients have unique laboratory and clinical characteristics. These findings may help further understand pSS, IgG4-RD, and the role of IgG4+ plasma cells in autoimmune diseases. References Giovelli RA, Santos MC, Serrano ΈV, Valim V. Clinical characteristics and biopsy accuracy in suspected cases of Sjögren's syndrome referred to labial salivary gland biopsy. BMC Musculoskelet Disord. 2015; 15;16:30. John HS, Yoh Z, Vikram D: IgG4-related disease. N Engl J Med 2012; 366:539–551. Disclosure of Interest None declared

Expression of MMP-3 in Labial Glands of Primary Sjogren′s Syndrome Patients

Expressions of MMP-1,MMP-8 and MMP-13 in gingival tissue of patients with aggressive periodontitis

Expression and Significance of Matrix Metalloproteinase in Labial Salivary Glands of Patients with Sjgren's Syndrome

[Mrna Expression of Procollagen and SMADs in Lesional Skin of Progressive Systemic Sclerosis].

Clinical Analysis: Aqueous-Deficient and Meibomian Gland Dysfunction in Patients with Primary Sjogren's Syndrome

Follicular Helper T Cells and Follicular Regulatory T Cells in the Immunopathology of Primary Sjögren's Syndrome

Follicular helper T cells and follicular regulatory T cells in the immunopathology of primary Sjogren's syndrome

Biomarkers for Primary Sjögren’s Syndrome

Interleukin-17 expression in salivary glands and peripheral blood of patients with primary Sjogren's syndrome

The role of muscarinic acetylcholine receptor type 3 polypeptide (M3RP205-220) antibody in the saliva of patients with primary Sjögren's syndrome.

Single-cell transcriptomic analysis uncovers heterogeneity in the labial gland microenvironment of primary Sjögren's syndrome

Characteristics of Primary Sjögren’s Syndrome Patients with IgG4 Positive Plasma Cells Infiltration in the Labial Salivary Glands

Integrated Bioinformatics and Validation Reveal Potential Biomarkers Associated With Progression of Primary Sjögren's Syndrome

OP0185 Characteristics of Primary Sjögren's Syndrome Patients with IGG4-Positive Plasma Cells in Labial Salivary Glands

Clinical Significance of the Expression Levels of Serum Transforming Growth Factor-Β and CXC Type Chemokine Ligand 13 in Primary Sjogren's Syndrome Patients.

[Expression of CD4+ CD25+ Regulatory T Cells in Peripheral Blood and Salivary Gland of Patients with Primary Sjögren's Syndrome].

LONG NON-CODING RNA EXPRESSION PROFILE IN MINOR SALIVARY GLAND OF SJOGREN’S SYNDROME

Expression of osteopontin in labial salivary glands in patients with Sjogren's syndrome

Aberrant expression of the innate restriction factor bone marrow stromal antigen-2 in primary Sjögren's syndrome.

Differential long non-coding RNA expression profile and function analysis in primary Sjogren’s syndrome

Mir‐146a and Mir‐155 Expression in PBMCs from Patients with Sjögren's Syndrome